The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Surgical Absorbable Hemostatic Market Research Report 2024

Global Surgical Absorbable Hemostatic Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1769474

No of Pages : 107

Ask Your Query

Synopsis
Surgical Absorbable Hemostatic is used adjunctively in surgical procedures to assist in the control of capillary, venous and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective.

Global Surgical Absorbable Hemostatic market is projected to reach US$ 4204.6 million in 2029, increasing from US$ 2568 million in 2022, with the CAGR of 7.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Surgical Absorbable Hemostatic market research.

Key manufacturers engaged in the Surgical Absorbable Hemostatic industry include Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences and Zhonghui Shengxi, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Surgical Absorbable Hemostatic were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Surgical Absorbable Hemostatic market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Surgical Absorbable Hemostatic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Johnson & Johnson
  • BD
  • Baxter
  • B.Braun
  • Cura Medical
  • GELITA MEDICAL
  • Curasan AG
  • Meril Life Sciences
  • Zhonghui Shengxi
  • Beijing Datsing Bio-tech
  • Guizhou Jin Jiu Biotech
  • Beijing Taikesiman
  • Foryou Medical
  • Saikesaisi Holdings Group
  • Biotemed

Segment by Type

  • Hemostatic Gauze
  • Styptic Powder
  • Gelatin Sponge
  • Other

Segment by Application

  • Gynecology
  • Orthopedics
  • General Surgery
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Surgical Absorbable Hemostatic report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Surgical Absorbable Hemostatic Market Overview
1.1 Product Overview and Scope of Surgical Absorbable Hemostatic
1.2 Surgical Absorbable Hemostatic Segment by Type
1.2.1 Global Surgical Absorbable Hemostatic Market Value Comparison by Type (2023-2029)
1.2.2 Hemostatic Gauze
1.2.3 Styptic Powder
1.2.4 Gelatin Sponge
1.2.5 Other
1.3 Surgical Absorbable Hemostatic Segment by Application
1.3.1 Global Surgical Absorbable Hemostatic Market Value by Application: (2023-2029)
1.3.2 Gynecology
1.3.3 Orthopedics
1.3.4 General Surgery
1.3.5 Other
1.4 Global Surgical Absorbable Hemostatic Market Size Estimates and Forecasts
1.4.1 Global Surgical Absorbable Hemostatic Revenue 2018-2029
1.4.2 Global Surgical Absorbable Hemostatic Sales 2018-2029
1.4.3 Global Surgical Absorbable Hemostatic Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Surgical Absorbable Hemostatic Market Competition by Manufacturers
2.1 Global Surgical Absorbable Hemostatic Sales Market Share by Manufacturers (2018-2023)
2.2 Global Surgical Absorbable Hemostatic Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Surgical Absorbable Hemostatic Average Price by Manufacturers (2018-2023)
2.4 Global Surgical Absorbable Hemostatic Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Surgical Absorbable Hemostatic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Surgical Absorbable Hemostatic, Product Type & Application
2.7 Surgical Absorbable Hemostatic Market Competitive Situation and Trends
2.7.1 Surgical Absorbable Hemostatic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Surgical Absorbable Hemostatic Players Market Share by Revenue
2.7.3 Global Surgical Absorbable Hemostatic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Surgical Absorbable Hemostatic Retrospective Market Scenario by Region
3.1 Global Surgical Absorbable Hemostatic Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Surgical Absorbable Hemostatic Global Surgical Absorbable Hemostatic Sales by Region: 2018-2029
3.2.1 Global Surgical Absorbable Hemostatic Sales by Region: 2018-2023
3.2.2 Global Surgical Absorbable Hemostatic Sales by Region: 2024-2029
3.3 Global Surgical Absorbable Hemostatic Global Surgical Absorbable Hemostatic Revenue by Region: 2018-2029
3.3.1 Global Surgical Absorbable Hemostatic Revenue by Region: 2018-2023
3.3.2 Global Surgical Absorbable Hemostatic Revenue by Region: 2024-2029
3.4 North America Surgical Absorbable Hemostatic Market Facts & Figures by Country
3.4.1 North America Surgical Absorbable Hemostatic Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Surgical Absorbable Hemostatic Sales by Country (2018-2029)
3.4.3 North America Surgical Absorbable Hemostatic Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Surgical Absorbable Hemostatic Market Facts & Figures by Country
3.5.1 Europe Surgical Absorbable Hemostatic Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Surgical Absorbable Hemostatic Sales by Country (2018-2029)
3.5.3 Europe Surgical Absorbable Hemostatic Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Surgical Absorbable Hemostatic Market Facts & Figures by Country
3.6.1 Asia Pacific Surgical Absorbable Hemostatic Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Surgical Absorbable Hemostatic Sales by Country (2018-2029)
3.6.3 Asia Pacific Surgical Absorbable Hemostatic Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Surgical Absorbable Hemostatic Market Facts & Figures by Country
3.7.1 Latin America Surgical Absorbable Hemostatic Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Surgical Absorbable Hemostatic Sales by Country (2018-2029)
3.7.3 Latin America Surgical Absorbable Hemostatic Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Surgical Absorbable Hemostatic Market Facts & Figures by Country
3.8.1 Middle East and Africa Surgical Absorbable Hemostatic Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Surgical Absorbable Hemostatic Sales by Country (2018-2029)
3.8.3 Middle East and Africa Surgical Absorbable Hemostatic Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Surgical Absorbable Hemostatic Sales by Type (2018-2029)
4.1.1 Global Surgical Absorbable Hemostatic Sales by Type (2018-2023)
4.1.2 Global Surgical Absorbable Hemostatic Sales by Type (2024-2029)
4.1.3 Global Surgical Absorbable Hemostatic Sales Market Share by Type (2018-2029)
4.2 Global Surgical Absorbable Hemostatic Revenue by Type (2018-2029)
4.2.1 Global Surgical Absorbable Hemostatic Revenue by Type (2018-2023)
4.2.2 Global Surgical Absorbable Hemostatic Revenue by Type (2024-2029)
4.2.3 Global Surgical Absorbable Hemostatic Revenue Market Share by Type (2018-2029)
4.3 Global Surgical Absorbable Hemostatic Price by Type (2018-2029)
5 Segment by Application
5.1 Global Surgical Absorbable Hemostatic Sales by Application (2018-2029)
5.1.1 Global Surgical Absorbable Hemostatic Sales by Application (2018-2023)
5.1.2 Global Surgical Absorbable Hemostatic Sales by Application (2024-2029)
5.1.3 Global Surgical Absorbable Hemostatic Sales Market Share by Application (2018-2029)
5.2 Global Surgical Absorbable Hemostatic Revenue by Application (2018-2029)
5.2.1 Global Surgical Absorbable Hemostatic Revenue by Application (2018-2023)
5.2.2 Global Surgical Absorbable Hemostatic Revenue by Application (2024-2029)
5.2.3 Global Surgical Absorbable Hemostatic Revenue Market Share by Application (2018-2029)
5.3 Global Surgical Absorbable Hemostatic Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Johnson & Johnson Surgical Absorbable Hemostatic Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BD Surgical Absorbable Hemostatic Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Baxter
6.3.1 Baxter Corporation Information
6.3.2 Baxter Description and Business Overview
6.3.3 Baxter Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Baxter Surgical Absorbable Hemostatic Product Portfolio
6.3.5 Baxter Recent Developments/Updates
6.4 B.Braun
6.4.1 B.Braun Corporation Information
6.4.2 B.Braun Description and Business Overview
6.4.3 B.Braun Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.4.4 B.Braun Surgical Absorbable Hemostatic Product Portfolio
6.4.5 B.Braun Recent Developments/Updates
6.5 Cura Medical
6.5.1 Cura Medical Corporation Information
6.5.2 Cura Medical Description and Business Overview
6.5.3 Cura Medical Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cura Medical Surgical Absorbable Hemostatic Product Portfolio
6.5.5 Cura Medical Recent Developments/Updates
6.6 GELITA MEDICAL
6.6.1 GELITA MEDICAL Corporation Information
6.6.2 GELITA MEDICAL Description and Business Overview
6.6.3 GELITA MEDICAL Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GELITA MEDICAL Surgical Absorbable Hemostatic Product Portfolio
6.6.5 GELITA MEDICAL Recent Developments/Updates
6.7 Curasan AG
6.6.1 Curasan AG Corporation Information
6.6.2 Curasan AG Description and Business Overview
6.6.3 Curasan AG Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Curasan AG Surgical Absorbable Hemostatic Product Portfolio
6.7.5 Curasan AG Recent Developments/Updates
6.8 Meril Life Sciences
6.8.1 Meril Life Sciences Corporation Information
6.8.2 Meril Life Sciences Description and Business Overview
6.8.3 Meril Life Sciences Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Meril Life Sciences Surgical Absorbable Hemostatic Product Portfolio
6.8.5 Meril Life Sciences Recent Developments/Updates
6.9 Zhonghui Shengxi
6.9.1 Zhonghui Shengxi Corporation Information
6.9.2 Zhonghui Shengxi Description and Business Overview
6.9.3 Zhonghui Shengxi Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Zhonghui Shengxi Surgical Absorbable Hemostatic Product Portfolio
6.9.5 Zhonghui Shengxi Recent Developments/Updates
6.10 Beijing Datsing Bio-tech
6.10.1 Beijing Datsing Bio-tech Corporation Information
6.10.2 Beijing Datsing Bio-tech Description and Business Overview
6.10.3 Beijing Datsing Bio-tech Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Beijing Datsing Bio-tech Surgical Absorbable Hemostatic Product Portfolio
6.10.5 Beijing Datsing Bio-tech Recent Developments/Updates
6.11 Guizhou Jin Jiu Biotech
6.11.1 Guizhou Jin Jiu Biotech Corporation Information
6.11.2 Guizhou Jin Jiu Biotech Surgical Absorbable Hemostatic Description and Business Overview
6.11.3 Guizhou Jin Jiu Biotech Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Guizhou Jin Jiu Biotech Surgical Absorbable Hemostatic Product Portfolio
6.11.5 Guizhou Jin Jiu Biotech Recent Developments/Updates
6.12 Beijing Taikesiman
6.12.1 Beijing Taikesiman Corporation Information
6.12.2 Beijing Taikesiman Surgical Absorbable Hemostatic Description and Business Overview
6.12.3 Beijing Taikesiman Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Beijing Taikesiman Surgical Absorbable Hemostatic Product Portfolio
6.12.5 Beijing Taikesiman Recent Developments/Updates
6.13 Foryou Medical
6.13.1 Foryou Medical Corporation Information
6.13.2 Foryou Medical Surgical Absorbable Hemostatic Description and Business Overview
6.13.3 Foryou Medical Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Foryou Medical Surgical Absorbable Hemostatic Product Portfolio
6.13.5 Foryou Medical Recent Developments/Updates
6.14 Saikesaisi Holdings Group
6.14.1 Saikesaisi Holdings Group Corporation Information
6.14.2 Saikesaisi Holdings Group Surgical Absorbable Hemostatic Description and Business Overview
6.14.3 Saikesaisi Holdings Group Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Saikesaisi Holdings Group Surgical Absorbable Hemostatic Product Portfolio
6.14.5 Saikesaisi Holdings Group Recent Developments/Updates
6.15 Biotemed
6.15.1 Biotemed Corporation Information
6.15.2 Biotemed Surgical Absorbable Hemostatic Description and Business Overview
6.15.3 Biotemed Surgical Absorbable Hemostatic Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Biotemed Surgical Absorbable Hemostatic Product Portfolio
6.15.5 Biotemed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Surgical Absorbable Hemostatic Industry Chain Analysis
7.2 Surgical Absorbable Hemostatic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Surgical Absorbable Hemostatic Production Mode & Process
7.4 Surgical Absorbable Hemostatic Sales and Marketing
7.4.1 Surgical Absorbable Hemostatic Sales Channels
7.4.2 Surgical Absorbable Hemostatic Distributors
7.5 Surgical Absorbable Hemostatic Customers
8 Surgical Absorbable Hemostatic Market Dynamics
8.1 Surgical Absorbable Hemostatic Industry Trends
8.2 Surgical Absorbable Hemostatic Market Drivers
8.3 Surgical Absorbable Hemostatic Market Challenges
8.4 Surgical Absorbable Hemostatic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock